New Biomarker Oncogene For The Early Detection of Breast Cancer December 27, 2016 News SNU An oncogene discovered by NUS scientists could be used as a biomarker for the early detection and prognosis of breast cancer. This may happen as soon as next year, as the patent has been licensed [..]
International Engineering & Technology Fair 02-04 Feb 2017 Pragati Maidan, New Delhi, India 22nd IETF 2017 The International Engineering and Technology Fair is now in its 22nd edition. A comprehensive business-to-business event segmented into 11 focused engineering and manufacturing sections, the event is an unparalleled platform for networking and getting discovered [..]
Effect of “Ineffective” Treatment on Some Glioblastoma Patients December 26, 2016 By KRISTA CONGER (Stanford News) A subgroup of patients with a devastating brain tumor called glioblastoma multiforme benefited from treatment with a class of chemotherapy drugs that two previous large clinical trials indicated was ineffective against the disease, according to a [..]
Now Its Easy to Monitor Autoimmune Disease Progression By Gene Activity December 26, 2016 By JENNIE DUSHECK (Stanford News) Researchers at the Stanford University School of Medicine and six other institutions have designed a new diagnostic tool for a rare and deadly autoimmune disease that affects the skin and internal organs. [..]
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca December 23, 2016 Pfizer Inc. (NYSE:PFE) today announced that it has completed the acquisition of the development and commercialization rights to AstraZeneca’s late-stage small molecule anti-infective business, primarily outside the United States. The agreement includes the commercialization and development rights [..]
Final Trial Results Confirm Ebola Vaccine Provides High Protection Against Disease WHO News | GENEVA 23 DECEMBER 2016 An experimental Ebola vaccine was highly protective against the deadly virus in a major trial in Guinea, according to results published today in The Lancet. The vaccine is the first to prevent [..]
Artificial Leaf as Mini-Factory For Medicine Eindhoven University of Technology News December 22 2016 To produce medicine sustainably and cheaply, anywhere you want. Whether in the middle of the jungle or even on Mars. A ‘mini-factory’ whereby sunlight can be captured to make chemical products. Inspired by the art of [..]
Mystery Molecule is a Key to Inhibiting Colon Cancer St. Jude Children’s Research Hospital News December 22, 2016 Immunologists at St. Jude Children’s Research Hospital have discovered that a protein called NLRC3 plays a central role in inhibiting colon cells from becoming cancerous. The study, led by Thirumala-Devi Kanneganti, Ph.D., [..]
FDA Accepts Supplemental New Drug Application for Pfizer’s IBRANCE® (palbociclib) in HR+, HER2- Metastatic Breast Cancer December 22, 2016 Pfizer Inc. (NYSE:PFE) announced that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental New Drug Application (sNDA) for its first-in-class CDK 4/6 inhibitor, IBRANCE® (palbociclib). The [..]
Microbiotica: Sangar Institute Spin-out; Will Get £8m Funding From Cambridge Innovation Capital plc and IP Group plc By : Media Team Sangar Institute December 21, 2016 Cambridge Innovation Capital plc (CIC), a Cambridge-based investor in technology and healthcare companies, and IP Group plc, the developer of intellectual property-based businesses, announce the creation [..]
Sangar Institute Research Reveal Potential Drug Target From Largest Ever Genetic study of Primary Sclerosing Cholangitis By : Media Team Sangar Institute December 21, 2016 Primary Sclerosing Cholangitis (PSC) is a debilitating rare disease of the liver with no effective treatment. Reported in Nature Genetics researchers from the Wellcome Trust Sanger [..]
New Diabetes Approaches From Bacteria That Boost Insulin-Producing Cells By Lewis Taylor, University Communications December 21, 2016 A newly discovered bacterial protein produced in the zebrafish gut triggers insulin-producing beta cells of the pancreas to multiply during early larval development, say University of Oregon researchers. The research potentially has human health [..]
FDA Approved Rubraca™ (Rucaparib) of Clovis Oncology For the Treatment of Advanced Ovarian Cancer due to BRCA Mutations December 20, 2016 Rubraca received approval under the FDA’s accelerated approval program based on objective response rate and duration of response Most common Grade 3-4 adverse reaction was anemia; most common Grade 3-4 laboratory [..]
Pfizer Receives Approval in the European Union for Nimenrix™ (Meningococcal Group A, C, W-135, and Y Conjugate Vaccine) in Infants Six Weeks of Age and Older Pfizer NEWS December 20, 2016 Pfizer Inc. (NYSE:PFE) announced that the European Commission (EC) has approved an expanded indication for Nimenrix™ (meningococcal group [..]
Open Source Leadership Summit 2017 Dates: February 14-16, 2017 | Request an invitation here Submit a speaking proposal here Location: Lake Tahoe, The United States The Linux Foundation Open Source Leadership Summit is where the world’s thought leaders in open source software and collaborative development convene to share best practices and learn how [..]
Movable Microplatform Floats On a Sea of Droplets David L. Chandler | MIT News Office December 19, 2016 Microelectromechanical systems, or MEMS, are tiny machines fabricated using equipment and processes developed for the production of electronic chips and devices. They’ve found a wide variety of applications in today’s consumer electronics, [..]
A Leap in Bioinspired Robotics Jennifer Chu | MIT News Office December 19, 2016 In the not so distant future, first responders to a disaster zone may include four-legged, dog-like robots that can bound through a fire or pick their way through a minefield, rising up on their hind legs to [..]
Faster treatment for epilepsy NUS News 16 December 2016 Researchers at Duke-NUS Medical School (Duke-NUS) have identified a gene network in the brain, that when disrupted, causes epilepsy. The team’s original “network biology” approach could also possibly provide a quicker and cheaper way to accelerate the discovery of novel drug [..]
FDA Clears Integration Between LifeScan’s OneTouch Verio Flex® Blood Glucose Monitoring System and WellDoc’s BlueStar® Diabetes Management Platform J&J News December 17, 2016 LifeScan, Inc., part of the Johnson & Johnson Diabetes Care Companies and a world leader in blood glucose monitoring, today announced the U.S. Food and Drug Administration (FDA) [..]
Novartis receives positive CHMP recommendation for Ilaris® to treat rare diseases in adults and children called Periodic Fever Syndromes Ilaris® (canakinumab) is recommended for approval in Europe for the treatment of three Periodic Fever Syndromes: TRAPS, HIDS/MKD and FMF disease If approved, Ilaris will be the first and only [..]
Novartis bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited Investigational ZPL389 showed a clinically and statistically significant improvement of eczema lesions, leading to a 50% reduction in EASI score compared to placebo after eight weeks of treatment with a favorable safety profile Eczema is a chronic, [..]
FDA Approves Removal Of Boxed Warning Regarding Serious Neuropsychiatric Events From CHANTIX® (varenicline) Labeling Labeling Revisions Also Include Updates to Corresponding Warning and Addition of Clinical Data on Superior Efficacy of CHANTIX Compared to Bupropion or Nicotine Patch1 Labeling Revisions May Further Encourage Smokers and Healthcare Providers to Discuss Smoking [..]
KEYTRUDA® (pembrolizumab) Demonstrated Improved Health-Related Quality of Life Compared to Chemotherapy in First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Findings Presented in Plenary Session at 17 th World Conference on Lung Cancer December 16, 2016 Merck (NYSE:MRK), known as MSD outside the United States and Canada, [..]
How do we keep GPS safe from sabotage? By Edmund Andrews (Stanford News) December 16, 2016 Aerial drones are already being used to televise football games, produce 3-D maps and tend farm fields. Uber, the giant ride-sharing company, is now testing a service with self-driving cars in Pittsburgh. China deploys unmanned patrol boats in [..]
No more burning batteries? Stanford scientists turn to AI to create safer lithium-ion batteries DECEMBER 16, 2016 BY: MARK SHWARTZ (Stanford News) Scientists have spent decades searching for a safe alternative to the flammable liquid electrolytes used in lithium-ion batteries. Now Stanford University researchers have identified nearly two-dozen solid electrolytes [..]
U of T Researchers Make Skin Cells ‘Crawl’ Together to Heal Wounds Treated With Unique Hydrogel Layer December 16, 2016 By Marit Mitchell (University Of Toronto) Time may not heal all wounds, but a proprietary mix of peptides and gel developed by U of T researchers heals most. A team led [..]
FDA Approves MACI for the Treatment of Symptomatic Cartilage Defects of the Knee in Adults December 16, 2016 (GLOBE NEWSWIRE) Vericel Corporation (NASDAQ:VCEL), a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that the U.S. Food and Drug Administration [..]
MIT Energy Initiative report provides guidance for evolving electric power sector Emily Dahl | MIT Energy Initiative December 16, 2016 Distributed energy resources — relatively small-scale power technologies such as solar, wind, energy storage, and power electronics and control devices — are being deployed rapidly in the global shift toward [..]
SEO BootCamp January 11-13, 2017, Dallas, TX The SEO Bootcamp, organized by the SEO Bootcamp will take place from 11th January to 13th January 2017 at the Level in Dallas, United States Of America. This Conference Will Cover Areas Like: – What really matters to Google and other search engines, [..]
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide) Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer By: Pfizer Press Release December 15, 2016 Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503) today announced the Phase 4 PLATO study, evaluating the efficacy and safety of [..]
Copyright © 2024 | WordPress Theme by MH Themes